Security key
869367102
Sutro Biopharma, Inc. - Common Stock, $0.001 par value per share (STRO)
CUSIP: 869367102
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 16,607,375
- Total 13F shares
- 63,895,959
- Share change
- -1,842,519
- Total reported value
- $117,565,386
- Put/Call ratio
- 26%
- Price per share
- $1.84
- Number of holders
- 122
- Value change
- -$7,306,459
- Number of buys
- 55
- Number of sells
- 66
Report period
Q4 2024
Institutions
122
Top holders
10
STRO full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
SUTRO BIOPHARMA, INC. SEC filings
SUTRO BIOPHARMA, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 869367102
Recent filing periods:
Top shareholders of STRO - Sutro Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
43%
|
7,187,495
|
$24,868,733 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
42%
|
7,016,119
|
$24,275,772 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
25%
|
4,195,072
|
$14,514,950 | — | 30 Sep 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
18%
|
2,997,453
|
$10,371,187 | — | 30 Sep 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
17%
|
2,832,064
|
$9,798,941 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
14%
|
2,250,132
|
$7,785,457 | — | 30 Sep 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
13%
|
2,196,814
|
$7,600,976 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
13%
|
2,126,655
|
$7,358,226 | — | 30 Sep 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
12%
|
2,066,447
|
$7,149,907 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
12%
|
2,031,745
|
$7,029,838 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
11%
|
1,856,956
|
$6,426,061 | — | 30 Sep 2024 | |
| Eversept Partners, LP |
13F
|
Company |
11%
|
1,841,989
|
$6,373,282 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
11%
|
1,746,268
|
$6,042,088 | — | 30 Sep 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
10%
|
1,716,132
|
$5,937,817 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
9.9%
|
1,647,162
|
$5,699,181 | — | 30 Sep 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
9.7%
|
1,609,874
|
$5,568,000 | — | 30 Sep 2024 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
9.1%
|
1,519,341
|
$5,256,920 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
7.2%
|
1,199,623
|
$4,150,695 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
5.9%
|
980,318
|
$3,391,985 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
5%
|
828,097
|
$2,865,216 | — | 30 Sep 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
4.9%
|
821,746
|
$2,843,241 | — | 30 Sep 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
4.9%
|
814,955
|
$2,852,343 | — | 30 Sep 2024 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
4.6%
|
762,498
|
$2,638,243 | — | 30 Sep 2024 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
4.4%
|
737,670
|
$2,552,338 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
3.7%
|
622,428
|
$2,153,601 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
3.6%
|
590,900
|
$2,044,514 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
3%
|
491,765
|
$1,701,507 | — | 30 Sep 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
2.6%
|
437,051
|
$1,512,196 | — | 30 Sep 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.2%
|
359,919
|
$1,245,320 | — | 30 Sep 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
2%
|
338,222
|
$1,170,248 | — | 30 Sep 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
2%
|
329,579
|
$1,140,343 | — | 30 Sep 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
2%
|
325,538
|
$1,126,362 | — | 30 Sep 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
1.7%
|
283,600
|
$981,256 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.7%
|
274,085
|
$948,337 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
1.6%
|
273,019
|
$944,645 | — | 30 Sep 2024 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1.6%
|
271,337
|
$938,826 | — | 30 Sep 2024 | |
| LPL Financial LLC |
13F
|
Company |
1.6%
|
269,899
|
$933,851 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.5%
|
251,995
|
$871,903 | — | 30 Sep 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
1.5%
|
244,809
|
$847,039 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.3%
|
215,049
|
$744,070 | — | 30 Sep 2024 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
1.1%
|
190,300
|
$658,438 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
1.1%
|
189,041
|
$654,082 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.1%
|
182,226
|
$630,502 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1%
|
167,645
|
$580,052 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
1%
|
165,859
|
$573,872 | — | 30 Sep 2024 | |
| Man Group plc |
13F
|
Company |
0.99%
|
163,928
|
$567,191 | — | 30 Sep 2024 | |
| STRS OHIO |
13F
|
Company |
0.92%
|
152,800
|
$528,688 | — | 30 Sep 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.91%
|
151,221
|
$523,225 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.78%
|
129,152
|
$446,866 | — | 30 Sep 2024 | |
| SHERBROOKE PARK ADVISERS LLC |
13F
|
Company |
0.78%
|
128,850
|
$445,821 | — | 30 Sep 2024 |
Institutional Holders of Sutro Biopharma, Inc. - Common Stock, $0.001 par value per share (STRO) as of Q4 2024
As of 31 Dec 2024,
Sutro Biopharma, Inc. - Common Stock, $0.001 par value per share (STRO) was held by
122 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,895,959 shares.
The largest 10 holders included
BlackRock, Inc., SUVRETTA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Kynam Capital Management, LP, Merck & Co., Inc., Vestal Point Capital, LP, CITADEL ADVISORS LLC, Point72 Asset Management, L.P., Samsara BioCapital, LLC, and MPM BIOIMPACT LLC.
This page lists
122
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
130
Q4 2024 holders
122
Holder diff
-8
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.